Russia supplies Avifavir anti-coronavirus drug to more than 15 countries

Business & Economy August 03, 2020, 20:52

Avifavir is one of the two registered COVID-19 drugs in the world

MOSCOW, August 3. /TASS/. Russia currently supplies the Avifavir anti-coronavirus drug to more than 15 countries, head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in an interview with the Rossiya-24 TV channel.

"This drug [Avifavir] is supplied to more than 15 countries," he said.

Dmitriev recalled that earlier today the sovereign wealth fund announced the start of supplies of Avifavir to South Africa and a number of Latin American countries. In addition, the drug is supplied to neighboring countries, he added.

Sales of the anti-COVID drug are conducted by Chromis, a joint venture established by RDIF and ChemRar Group. Chromis is also the developer of the drug.

Avifavir is one of the two registered COVID-19 drugs in the world. It also became the first Favipiravir-based drug in the world approved for treatment of COVID-19. It showed high efficacy in clinical trials, disrupting the reproduction mechanisms of coronavirus.

On May 29, Avifavir received a registration certificate from Russia’s Ministry of Health and became the first Russian drug approved for treatment of COVID-19 patients. On June 3, the Ministry of Health included Avifavir in the seventh edition of the guidelines for the prevention, diagnosis and treatment of the novel coronavirus infection.

Read more on the site →